drugset / Trial / NCT00878995

Testosterone for Treating Cachexia in Patients With Squamous Cell Carcinoma

NCT00878995

RandomizedParallel-groupQuadruple-blindSupportive care

Summary

RATIONALE: Testosterone may lessen weight loss and improve muscle size and strength in patients with cachexia caused by cancer. PURPOSE: This randomized phase I trial is studying whether testosterone administered during standard of care chemotherapy and/or radiation works by helping patients with squamous cell carcinoma to maintain their body weight and muscle size and strength during treatment.

Timeline

Start
2009-06-03
Primary completion
2014-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Testosterone Enanthate Small molecule 100 mg Intramuscular